BVT Knock-Out PGR/ DE000VM656M4 /
11/8/2024 7:54:43 PM | Chg.+0.600 | Bid9:59:59 PM | Ask9:59:59 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
11.800EUR | +5.36% | - Bid Size: - |
- Ask Size: - |
Progressive Corporat... | 135.73 USD | 12/31/2078 | Call |
Newsfile Corp
10/13
SEE Shines at New York Climate Week, Highlighting Progressive Climate Solutions In China
GlobeNewswire
9/2
Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire
8/30
MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Paten...
GlobeNewswire
8/30
Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA App...
GlobeNewswire
8/29
The Alignment Studio Announces Launch of Women’s Health Physiotherapy Services in Melbourne
GlobeNewswire
8/28
AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodege...
GlobeNewswire
8/26
Avalyn Announces Upcoming Presentations on its Lead Program AP01, Inhaled Pirfenidone, for the Treat...
GlobeNewswire
8/22
Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive ...
GlobeNewswire
8/21
CPAClub™ and Caseware™ Partner to Elevate Audit Quality for Progressive Accounting Firms
GlobeNewswire
8/19
Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
GlobeNewswire
8/19
Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire
8/15
Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire
8/14
Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene ...
GlobeNewswire
8/14
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
GlobeNewswire
8/13
Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference